Immunosuppression by embryonic stem cells.

scientific article published on 25 October 2007

Immunosuppression by embryonic stem cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1634/STEMCELLS.2007-0151
P698PubMed publication ID17962705
P5875ResearchGate publication ID5882667

P2093author name stringPedro Geraldes
Jeffrey L Platt
Cody A Koch
P2860cites workEstablishment in culture of pluripotential cells from mouse embryosQ27860625
Embryonic stem cell lines derived from human blastocystsQ27861010
Derivation of completely cell culture-derived mice from early-passage embryonic stem cellsQ29547491
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolitesQ36376598
P433issue1
P921main subjectimmunosuppressionQ1455316
P304page(s)89-98
P577publication date2007-10-25
P1433published inStem CellsQ15724411
P1476titleImmunosuppression by embryonic stem cells.
P478volume26

Reverse relations

cites work (P2860)
Q37742101Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies
Q41853000Bone marrow-derived cells homing for self-repair of periodontal tissues: a histological characterization and expression analysis
Q36998531CD70-CD27 ligation between neural stem cells and CD4+ T cells induces Fas-FasL-mediated T-cell death
Q37610499Cells derived from iPSC can be immunogenic - yes or no?
Q33690008Concise review: mesenchymal stromal cells used for periodontal regeneration: a systematic review
Q41852461Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation
Q39262859Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
Q35473934Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells
Q89986366Embryonic stem cell extracts improve wound healing in diabetic mice
Q41853497Embryonic stem cell therapy of heart failure in genetic cardiomyopathy
Q34193128Embryonic stem cell-derived factors inhibit T effector activation and induce T regulatory cells by suppressing PKC-θ activation
Q26770126Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation
Q33564357Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells
Q41831145Expression of major histocompatibility complex class I proteins and their antigen processing chaperones in mouse embryonic stem cells from fertilized and parthenogenetic embryos
Q30828462F4/80+ Host Macrophages Are a Barrier to Murine Embryonic Stem Cell-Derived Hematopoietic Progenitor Engraftment In Vivo
Q37295081Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression
Q35624098Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
Q54415459Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells.
Q21245470Human embryonic stem cells hemangioblast express HLA-antigens
Q37372183Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives
Q36040255Hurdles to clinical translation of human induced pluripotent stem cells
Q47787334Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells
Q38113726Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives
Q36802900Immunogenicity of pluripotent stem cells and their derivatives
Q35957485Immunological Properties of Corneal Epithelial-Like Cells Derived from Human Embryonic Stem Cells
Q41242617Immunological Properties of Murine Parthenogenetic Stem Cells and Their Differentiation Products
Q34774684Immunological barriers to stem-cell based cardiac repair
Q41998193Immunological properties of embryonic and adult stem cells
Q84257326Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response
Q36861712Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts
Q37861021In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages.
Q43161029In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation
Q39040578Induced pluripotent stem cell technology: a decade of progress
Q48254157Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.
Q35155712Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro
Q40059574Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy
Q43169329MFG-E8 Is Critical for Embryonic Stem Cell-Mediated T Cell Immunomodulation.
Q37350071Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Q34352877Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts
Q34330274New and old technologies for organ replacement.
Q35876527Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo
Q37863548Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.
Q35234014Reduced immunogenicity of induced pluripotent stem cells derived from Sertoli cells
Q28600945Restoration of a Critical Mandibular Bone Defect Using Human Alveolar Bone-Derived Stem Cells and Porous Nano-HA/Collagen/PLA Scaffold
Q61959986Role of the Kynurenine Pathway in Stem Cell Biology
Q38175402Specific protein markers for stem cell cross-talk with neighboring cells in the environment
Q26861615Stem cell imaging: from bench to bedside
Q30381054Stem cell platforms for regenerative medicine
Q38003187Stem cells in the reproductive system
Q38040207Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.
Q39709204The immunosuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune responses
Q38149123The kynurenine pathway in stem cell biology.